The AT1Areceptor “gain-of-function” mutant N111S/Δ329 is both constitutively active and hyperreactive to angiotensin II
Open Access
- 1 May 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 290 (5) , E840-E848
- https://doi.org/10.1152/ajpendo.00458.2005
Abstract
The renin-angiotensin-aldosterone system (RAAS) is central to cardiovascular and renal physiology. However, there is no animal model in which the activation of the RAAS only reflects the activation of the angiotensin II (ANG II) AT1receptor. As a first step to developing such a model, we characterized a gain-of-function mutant of the mouse AT1Areceptor. This mutant carries two mutations: N111S predicted to activate the receptor constitutively and a COOH-terminal deletion, Δ329, expected to reduce receptor internalization and desensitization. We expressed this double mutant (AT1A-N111S/Δ329) in heterologous cells. It showed a pharmacological profile consistent with that of other constitutively active mutants. Furthermore, it increased basal production of inositol phosphates, as well as basal cytosolic and nuclear ERK activities. Basal proliferation of cells expressing the mutant was also greater than that of the wild type. The double mutant was poorly internalized and failed to recruit β-arrestin 2 in the presence of ANG II. It also showed hypersensitive and hyperreactive responses to ANG II for both inositol phosphate production and ERK activation. The additivity of the phenotypes of the two mutations makes this mutant an appropriate candidate to test the physiological consequences of the AT1Areceptor activation itself in transgenic animal models.Keywords
This publication has 27 references indexed in Scilit:
- Stable Interaction between β-Arrestin 2 and Angiotensin Type 1A Receptor Is Required for β-Arrestin 2-mediated Activation of Extracellular Signal-regulated Kinases 1 and 2Journal of Biological Chemistry, 2004
- Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II ReceptorJournal of Biological Chemistry, 2004
- A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophyTrends in Pharmacological Sciences, 2003
- AT1 Receptor Mutant Lacking Heterotrimeric G Protein Coupling Activates the Src-Ras-ERK Pathway without Nuclear Translocation of ERKsJournal of Biological Chemistry, 2002
- Constitutive Internalization of Constitutively Active Angiotensin II AT1A Receptor Mutants Is Blocked by Inverse AgonistsPublished by Elsevier ,2002
- Desensitization of AT1 Receptor-Mediated Cellular Responses Requires Long Term Receptor Down-Regulation in Bovine Adrenal Glomerulosa CellsEndocrinology, 1997
- Somatic Mutations of the Angiotensin II (AT1) Receptor Gene are Not Present in Aldosterone-Producing AdenomaJournal of Clinical Endocrinology & Metabolism, 1997
- A Constitutively Active Mutant PTH-PTHrP Receptor in Jansen-Type Metaphyseal ChondrodysplasiaScience, 1995
- A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious pubertyNature, 1993
- Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomasNature, 1993